Jacob Van Naarden, president of Lilly Oncology and Eli Lilly's head of corporate business development
Twenty-two years ago, in a theater on the bucolic campus of Princeton University, a sophomore named Jacob Van Naarden portrayed the …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Corxel to take oral GLP-1 public in the US via SPAC October 26, 2026
AstraZeneca's two-pill combo may extend Tagrisso's life in lung cancer October 25, 2026
Pfizer looks beyond lung cancer flop as BioNTech, Bristol Myers show early activity October 25, 2026
Merck and Moderna's cancer vaccine data were 'a triumph of science.' And now, the work begins
BioNTech, DualityBio ponder next steps for HER2 ADC after 'modest' breast cancer results
Roche takes victory lap with lung cancer pill's win over Amgen, Bristol Myers
Swiss biotech Windward Bio files for Nasdaq IPO to fund China-derived assets and in-house R&D
Bristol Myers reveals death in MS CAR-T trial, has answer for safety signal in lupus trial
Source link







